Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Avrobio Inc (NQ: AVRO)
13.31 USD  +0.26 (+1.99%)
Official Closing Price  /  Updated: 4:00 PM EST, Nov 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 96,200
Open 13.18
Bid (Size) 13.05 (6)
Ask (Size) 19.97 (1)
Prev. Close 13.05
Today's Range 12.92 - 13.82
52wk Range 11.85 - 28.52
Shares Outstanding 23,149,645
Dividend Yield N/A
Performance
YTD
-14.95%
-14.95%
1 Month
-5.06%
-5.06%
3 Month
-31.32%
-31.32%
6 Month
-25.73%
-25.73%
1 Year
-50.47%
-50.47%
Top News
More News
AVROBIO, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today reported financial results for the third quarter ended September 30, 2019 and provided a business... Read More
from Business Wire News Releases
AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR‑RD‑02 for the Treatment of Gaucher Disease
AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the Company’s investigational gene therapy,... Read More
from Business Wire News Releases
More News
Read More
AVROBIO Appoints Holly May as Chief Commercial Officer
from Business Wire News Releases
AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
from Business Wire News Releases
AVROBIO, Inc. to Present at Chardan’s 3rd Annual Genetic Medicines Conference
from Business Wire News Releases
AVROBIO, Inc. to Present at Upcoming Investor Conferences
from Business Wire News Releases
AVROBIO Appoints Georgette Verdin as Chief Human Resources Officer
from Business Wire News Releases
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from Business Wire News Releases
AVROBIO Reports Second Quarter 2019 Financial Results and Provides Business Update
from Business Wire News Releases
BIB's Holdings Could Mean 33% Gain Potential
category ETFs
from ETF Channel
AVROBIO, Inc. to Present at the 2019 Wedbush PacGrow Healthcare Conference
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.